Article ; Online: Amoxicillin+clavulanic acid in community acquired pneumonia
Asian Journal of Medical Sciences, Vol 13, Iss 8, Pp 235-
Past, present, and future from an Indian perspective
2022 Volume 244
Abstract: Community acquired pneumonia (CAP) is a major health problem in India with high morbidity and mortality. The threat posed by this infection is further intensified by the continued emergence of resistance to the currently available antibiotics. With a ... ...
Abstract | Community acquired pneumonia (CAP) is a major health problem in India with high morbidity and mortality. The threat posed by this infection is further intensified by the continued emergence of resistance to the currently available antibiotics. With a heritage of more than 24 years in India, amoxicillin+clavulanic acid is one of the most common antibiotics used for CAP. It was developed with an intent to sustain the efficacy of amoxicillin which was challenged due to the emergence of the beta-lactamase producing microorganism. Over a period, it has been included in national and international guidelines for the treatment of CAP. To assure the highest probability of clinical cure and to combat development of resistance: It is imperative for amoxicillin+clavulanic acid to reaffirm itself. Optimization of the PK/PD and higher dose of amoxicllin+clavulanic acid will tackle the burden of the future difficult to manage respiratory infections. |
---|---|
Keywords | amoxicillin ; amoxicillin clavulanic acid ; antimicrobial resistance ; antibiotic resistance ; cap ; community acquired pneumonia ; pneumonia ; Medicine ; R |
Subject code | 290 |
Language | English |
Publishing date | 2022-08-01T00:00:00Z |
Publisher | Manipal College of Medical Sciences, Pokhara |
Document type | Article ; Online |
Database | BASE - Bielefeld Academic Search Engine (life sciences selection) |
Full text online
More links
Kategorien
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.